| Orchid Cove At Clearwater | |
| 1980 Sunset Point Rd, Clearwater, Florida 33765 | |
| (727) 443-1588 | |
| Name | Orchid Cove At Clearwater |
|---|---|
| Location | 1980 Sunset Point Rd, Clearwater, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 78.33% |
| Medicare ID (CCN) | 105373 |
| Legal Business Name | Clearwater Fl Opco Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1093497257 |
| Organization Name | SAND KEY POST ACUTE LLC |
| Address | 1980 Sunset Point Rd, Clearwater, FL 33765 |
| Phone Number | 727-443-1588 |
News Archive
News reports follow Families USA's continuing rollout of state-by-state studies on the number of small businesses that will be eligible for tax credits to help cover health costs under the new overhaul law, a vast majority according to the studies.
The current special issue of Technology and Innovation, Journal of the National Academy of Inventors, Volume 18, Number 1 (all open access), is devoted to the evolution of neuroimaging technology, with seven articles chronicling the latest advances in this critical area.
The preoperative shoulder CT scan is entered into special software, which then generates a 3D model of the patient's anatomy. Physicians use the model to examine the patient's anatomy, plan incision points, mark the points for the anchor pins, and adjust the prosthetic device.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
› Verified 4 days ago
| NPI Number | 1104430958 |
| Organization Name | CLEARWATER FL OPCO LLC |
| Doing Business As | SAND KEY HEALTH AND REHABILITATION CENTER |
| Address | 1980 Sunset Point Rd, Clearwater, FL 33765 |
| Phone Number | 727-443-1588 |
News Archive
News reports follow Families USA's continuing rollout of state-by-state studies on the number of small businesses that will be eligible for tax credits to help cover health costs under the new overhaul law, a vast majority according to the studies.
The current special issue of Technology and Innovation, Journal of the National Academy of Inventors, Volume 18, Number 1 (all open access), is devoted to the evolution of neuroimaging technology, with seven articles chronicling the latest advances in this critical area.
The preoperative shoulder CT scan is entered into special software, which then generates a 3D model of the patient's anatomy. Physicians use the model to examine the patient's anatomy, plan incision points, mark the points for the anchor pins, and adjust the prosthetic device.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
› Verified 4 days ago
| NPI Number | 1235916560 |
| Organization Name | SUNSET POINT ROAD OPCO LLC |
| Address | 1980 Sunset Point Rd, Clearwater, FL 33765 |
| Phone Number | 727-443-1588 |
News Archive
News reports follow Families USA's continuing rollout of state-by-state studies on the number of small businesses that will be eligible for tax credits to help cover health costs under the new overhaul law, a vast majority according to the studies.
The current special issue of Technology and Innovation, Journal of the National Academy of Inventors, Volume 18, Number 1 (all open access), is devoted to the evolution of neuroimaging technology, with seven articles chronicling the latest advances in this critical area.
The preoperative shoulder CT scan is entered into special software, which then generates a 3D model of the patient's anatomy. Physicians use the model to examine the patient's anatomy, plan incision points, mark the points for the anchor pins, and adjust the prosthetic device.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
› Verified 4 days ago
| NPI Number | 1801810551 |
| Organization Name | 1980 SUNSET POINT ROAD LLC |
| Doing Business As | SUNSET POINT |
| Address | 1980 Sunset Point Rd, Clearwater, FL 33765 |
| Phone Number | 727-443-1588 |
News Archive
News reports follow Families USA's continuing rollout of state-by-state studies on the number of small businesses that will be eligible for tax credits to help cover health costs under the new overhaul law, a vast majority according to the studies.
The current special issue of Technology and Innovation, Journal of the National Academy of Inventors, Volume 18, Number 1 (all open access), is devoted to the evolution of neuroimaging technology, with seven articles chronicling the latest advances in this critical area.
The preoperative shoulder CT scan is entered into special software, which then generates a 3D model of the patient's anatomy. Physicians use the model to examine the patient's anatomy, plan incision points, mark the points for the anchor pins, and adjust the prosthetic device.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
› Verified 4 days ago
| NPI Number | 1942545652 |
| Address | 1980 Sunset Point Rd, Clearwater, FL 33765 |
| Phone Number | 727-443-1588 |
News Archive
News reports follow Families USA's continuing rollout of state-by-state studies on the number of small businesses that will be eligible for tax credits to help cover health costs under the new overhaul law, a vast majority according to the studies.
The current special issue of Technology and Innovation, Journal of the National Academy of Inventors, Volume 18, Number 1 (all open access), is devoted to the evolution of neuroimaging technology, with seven articles chronicling the latest advances in this critical area.
The preoperative shoulder CT scan is entered into special software, which then generates a 3D model of the patient's anatomy. Physicians use the model to examine the patient's anatomy, plan incision points, mark the points for the anchor pins, and adjust the prosthetic device.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
News reports follow Families USA's continuing rollout of state-by-state studies on the number of small businesses that will be eligible for tax credits to help cover health costs under the new overhaul law, a vast majority according to the studies.
The current special issue of Technology and Innovation, Journal of the National Academy of Inventors, Volume 18, Number 1 (all open access), is devoted to the evolution of neuroimaging technology, with seven articles chronicling the latest advances in this critical area.
The preoperative shoulder CT scan is entered into special software, which then generates a 3D model of the patient's anatomy. Physicians use the model to examine the patient's anatomy, plan incision points, mark the points for the anchor pins, and adjust the prosthetic device.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7215 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 23.55 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.38 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 23.47 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.19 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.2 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.96 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.75 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.12 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.09 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 85.71 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.63 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 42 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 31.31 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.45 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.03 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 53.58 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.57 | 82.93 |
News Archive
News reports follow Families USA's continuing rollout of state-by-state studies on the number of small businesses that will be eligible for tax credits to help cover health costs under the new overhaul law, a vast majority according to the studies.
The current special issue of Technology and Innovation, Journal of the National Academy of Inventors, Volume 18, Number 1 (all open access), is devoted to the evolution of neuroimaging technology, with seven articles chronicling the latest advances in this critical area.
The preoperative shoulder CT scan is entered into special software, which then generates a 3D model of the patient's anatomy. Physicians use the model to examine the patient's anatomy, plan incision points, mark the points for the anchor pins, and adjust the prosthetic device.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
› Verified 4 days ago
Orchid Cove At Clearwater Location: 1980 Sunset Point Rd, Clearwater, Florida 33765 Phone: (727) 443-1588 | |
Kensington Gardens Rehab And Nursing Center Location: 2055 Palmetto St, Clearwater, Florida 33758 Phone: (727) 461-6613 | |
Palm Garden Of Clearwater Location: 3480 Mcmullen Booth Rd, Clearwater, Florida 33761 Phone: (727) 786-6697 |